Vaccine against colibacillosis
US-2017028046-A1 · Feb 2, 2017 · US
US9937271B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9937271-B2 |
| Application number | US-201415039628-A |
| Country | US |
| Kind code | B2 |
| Filing date | Nov 25, 2014 |
| Priority date | Nov 26, 2013 |
| Publication date | Apr 10, 2018 |
| Grant date | Apr 10, 2018 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present invention provides an agent for controlling Escherichia coli diarrhea comprising a Shiga toxin as an active ingredient.
Opening claim text (preview).
The invention claimed is: 1. A method for controlling Escherichia coli diarrhea. in a pig infected with the Escherichia coli , the method comprising administering a Shiga toxin or a transformant containing the Shiga toxin to the pig in need thereof, wherein the Shiga toxin is a hybrid protein comprising two Shiga toxin B subunit proteins (Stx2eB) tandemly linked via a peptide linker, and wherein the Escherichia coli produces heat-labile toxin (LT) and/or heat-stable toxin (ST)…
Human Necessities · mapped topic
Human Necessities · mapped topic
Human Necessities · mapped topic
Human Necessities · mapped topic
Chemistry & Metallurgy · mapped topic
Related publications grouped by family.
Free tools are coming soon. Tell us what you want to track and we'll notify you.
Answers are generated from the same data shown on this page.